Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good move! And remember, heaven forbid we're not above $6 by year end (or April 14), one can recharacterize those shares back to Traditional.
Exactly! Those who say it doesn't exist are likely hooked into the criminal activity.
That's an appropriate label. Though shorting in itself is not illegal, collusion and naked shorting ARE!
For tax-conscious investors...
It would be a great time to convert any Traditional IRA shares to Roth, especially if you're over 59-1/2 (accessibility). If the strategy doesn't work out (heaven forbid), one can always recharacterize back to Traditional, without tax consequences or penalties.
Also, would be a good time to contribute to your Roth and buy AVXL shares. This morning, I sold $13k worth of AVXL shares in my taxable acct at $3.30 (long-term gains), contributed $6500, each, to my and my wife's Roths, then repurchased additional AVXL shares in those respective accts.
I emailed the company's atty yesterday and received the below response...
"Thank you for your email. The Company is equally concerned with the recent trading activity and is taking numerous actions in response to this activity including contacting the regulatory authorities."
Hopefully, we'll see something soon!
I haven't traded any shares, yet. Was thinking about it last Wed, expecting a spike on good news, but the cabal had a different plan (like in Nov) to slam it before the news could be digested.
I don't look at the technicals much; when I do it's usually the slow stochastic and money flow to identify overbought/oversold areas.
Until Anavex can get notoriety with more public demand, we'll continue to be encumbered by the cabal. It will likely require a partnership for that to happen. IMO, by year's end.
mike, you really need to do some serious research on the subject, because it is much bigger than just AF; he's just the tip of the iceberg. He's not the one doing the damage; he's just the most visible part of it.
Thanks. And I'll add... if the SEC is not part of the solution, then it must be that they're part of the problem.
Yep... Cramer helped start it. Nuff said.
Exactly. AF is associated with hedge funds that prey on microcap bios. One is TheStreet.com. It's common knowledge and likely have bought out the SEC.
Of course, shorts established their positions higher; some might have covered and the others are still being assisted by the manipulation of the cabal (many 100-share trades to keep downward pressure on the price).
How can you "know" that the price is going lower, unless you have some insight into the cabal's game plan? You can't know what the majority of retail is doing.
Potential catalysts over the coming weeks:
- PK/PD analysis
- Rett's trial news
- Parkinson's trial news
- Partnership news
- Alz P3 news
Great buy! In the following months, you'll be glad you did!
MANIPULATION! (primarily) The cabal drives the SP of many microcap bios up and down to where ever they want it. They now want to create tremendous fear to shake out as much retail as possible.
Savvy investors will find this as a great buying opportunity before the next catalyst hits.
These things will work out in due time; I have confidence in the company and the science.
Results did not disappoint one bit. Do you actually believe AF and Corey?
Patent extensions can and do occur. Question is if AVXL is working on one for 2-73 monotherapy.
Mitch , nice talking with you. Per our conversation, I'll garner help with the cover. Best...
If that's your true position, then you haven't done enough DD on the company, science and trial. The results were better than what the company was expecting. It included some very positive "unexpected therapeutic benefits".
This is purely an over reaction initiated by AF and the cabal. This will settle out and then turnaround with the next catalyst: PK/PD analysis, P3 announcement and/or partnership.
I knew you were, as was I.
But still might be worth trying something to raise awareness there. Cannot hurt.
Great! Let us know if you get a response.
The cabal really want to drive out retail... before the next catalyst, which could happen any week.
Does anyone here know Warren Buffett to convince him to invest a measly $5-$10M in AVXL?
That's not the kind of press or media I'm referring to.
Since this is a temporary orchestrated attack, it would be a bad idea to sell here. Hold out for next catalyst, at least: PK/PD analysis, P3 announcement and/or partnership.
Just wish we could get some positive press... some media coverage or interview that can generate the awareness we need.
Translation: There is no basis. LoL!
So, what's the basis for AXON to be valued at >$1.5B, with a previously failed drug?
I'm fairly certain that the first halt, at 1:01p, had to have been caused by the cabal. No retail investor could have received, read and digested the PR that quickly. It was a planned attack, regardless of the data presented.
How can you argue the point when AXON has a MC of > $1.5B with a previously failed drug?
It amazes me that several posters here still DO NOT UNDERSTAND THE PURPOSE AND DESIGN OF A P2 TRIAL. The FDA guided Anavex in its P2 trial design to be an adaptive, open label trial of 32 patients for the purpose of identifying maximum and optimal dosages, as well as the results from the two study arms: monotherapy and combo with donepezil. There's not supposed to be a larger number than 32 nor a placebo arm. The results of this adaptive, open label P2 will greatly increase the chances for a successful P3, which will indeed be larger (multiple locations) and potentially have a placebo arm, but more likely an SoC arm.
I disagree... what has hurt us are the planned attacks by the shorting cabal. PERIOD!
I agree... Anavex isn't a charity organization. Something is happening behind the scenes that warrants his increased pay and options. The nice thing about the options are the strike prices at $6.25 and $7.
I believe that we'll find the stories to be true and there will be more to come...perhaps not as impressive, but good nonetheless. Just because the pooled data didn't produce an amazing graph, doesn't mean that amazing improvements aren't happening. Don't discount the benefits of reduced depression, improved mood, demeanor and attitude.
Don't you think that the media story would have been aired with or without MacFarlane's participation? I do...
All I said was "it would seem that partner discussions are in progress". I didn't say that we have a partner lined up. You on the other hand, seem to think that nothing is happening since you've heard nothing. Which do you think is more accurate?
Because that is the normal course of progress, as stated by the CEO, who isn't sitting around doing nothing. You think that just because you hear nothing, that nothing is being done. Geez!
I think you're overlooking one VERY IMPORTANT fact... the FDA was involved in designing Anavex's adaptive open Phase2 trial. If the company and FDA are comfortable with the results, and they secure a partner and/or funding, this will move directly to Phase3.
Good points. I'm sure Clayton Parker has a very good relationship with the regulators and are having some conversations.
The "unusual trading activity" noted with the earlier subpoena, likely had to do with the short attack a few days BEFORE news was released in Nov. This time the cabal waited until the time of the release (but before anyone could appreciably ingest it).
2-73 + cannabinoid compound... interesting concept!